| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 16.960 | 25.952 | 27.794 | 11.589 | 18.235 | 23.415 | 15.358 | 22.194 |
| Total Income - EUR | - | 0 | 16.960 | 25.952 | 27.794 | 12.490 | 26.094 | 35.233 | 15.358 | 22.285 |
| Total Expenses - EUR | - | 502 | 4.812 | 5.305 | 19.871 | 28.806 | 15.140 | 27.154 | 21.809 | 20.848 |
| Gross Profit/Loss - EUR | - | -502 | 12.148 | 20.647 | 7.923 | -16.316 | 10.955 | 8.080 | -6.451 | 1.437 |
| Net Profit/Loss - EUR | - | -502 | 11.639 | 19.869 | 7.645 | -16.423 | 10.776 | 7.890 | -6.583 | 1.214 |
| Employees | - | 1 | 0 | 0 | 1 | 3 | 2 | 3 | 1 | 1 |
Check the financial reports for the company - Izorapid Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 45 | 12.380 | 35.030 | 44.945 | 21.128 | 34.259 | 19.293 | 9.764 | 8.467 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.206 | 1.674 | 503 |
| Receivables | - | 0 | 0 | 1.608 | 253 | 1.505 | 6.769 | 7.879 | 0 | 0 |
| Cash | - | 45 | 12.380 | 33.422 | 44.692 | 19.623 | 27.490 | 10.208 | 8.091 | 7.965 |
| Shareholders Funds | - | -457 | 11.190 | 30.853 | 37.900 | 18.835 | 29.193 | 14.868 | 8.239 | 6.784 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 502 | 1.190 | 4.177 | 7.044 | 2.030 | 5.066 | 4.426 | 1.525 | 1.683 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 264 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Izorapid Srl